Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Evaluation of Azacitidine Clinical Efficacy in Patients with Myelodysplasia Syndrome Dudina G.a., Golenkov a.K., Kataeva E.V., Mitina T.a. Moscow Regional Clinical Research Institute

Anatoly Golenkov, MD

Blood (2014) 124 (21): 5625.

https://doi.org/10.1182/blood.V124.21.5625.5625

Published: 2014

Journal Articles

Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era

Blood (2010) 116 (21): 3948.

https://doi.org/10.1182/blood.V116.21.3948.3948

Published: 2010

Journal Articles

Increased Peripheral T Cell Responses to EBV-Infected Cells with Frequent Detection of EBV-DNA In Plasma and Viral mRNA In Peripheral B-Cells In Immunocompetent EBV-Positive Diffuse Large B-Cell Lymphoma Patients

Satoko Morishima, MD, Kazuhito Yamamoto, MD, Hiroshi Kimura, MD, Seiko Iwata, MD, Tomohiro Kinoshita, MD, Hirokazu Nagai, MD, Isamu Sugiura, MD, Keitaro Tsushita, MD, Yoshitoyo Kagami, MD, Koichi Miyamura, MD, Kiyotaka Kuzushima, MD, Shigeo Nakamura, MD, Yasuo Morishima, MD

Blood (2010) 116 (21): 4163.

https://doi.org/10.1182/blood.V116.21.4163.4163

Published: 2010

Journal Articles

Efficacy and Safety of a Single-Course of Yttrium-90 Ibritumomab Tiuxetan for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma after/not Appropriate for Autologous Stem Cell Transplantation - Final Analysis of a Phase II Trial of the European MCL Network.

Oliver Weigert, MD, Christoph von Schilling, MD PhD, Mathias J. Rummel, MD PhD, Antonio Pezzutto, MD PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD PhD, Martin H. Dreyling, MD PhD

Blood (2007) 110 (11): 4501.

https://doi.org/10.1182/blood.V110.11.4501.4501

Published: 2007

Journal Articles

Clinicopathological Features of Pyothorax-Associated Lymphoma; a Retrospective Survey Involving 98 Patients.

Hiroto Narimatsu, MD, Yasunori Ota, MD, Masahiro Kami, MD, Kengo Takeuchi, MD, Ritsuro Suzuki, MD, Keitaro Matsuo, MD, Yukiko Kishi, MD, Tamae Hamaki, MD, Yuji Tanaka, MD, Shigeo Nakamura, MD

Blood (2006) 108 (11): 2445.

https://doi.org/10.1182/blood.V108.11.2445.2445

Published: 2006

Journal Articles

Efficacy and Safety of a Single-Course of Yttrium-90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed or Refractory Mantle Cell Lymphoma (MCL) After/Not Appropriate for Autologous Stem Cell Transplantation (ASCT) - A Phase II Trial of the European MCL Network.

Oliver Weigert, MD, Christoph von Schilling, MD, PhD, Mathias J. Rummel, MD, PhD, Antonio Pezzutto, MD, PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, PhD, Martin Dreyling, MD, PhD

Blood (2005) 106 (11): 4786.

https://doi.org/10.1182/blood.V106.11.4786.4786

Published: 2005

Journal Articles

Expression of Activation-Induced Cytidine Deaminase and Transcripts of Immunoglobulin Variable Heavy Chains in Mature B-Cell Lines Lacking Immunoglobulin Protein Expression.

Yoshinobu Matsuo, Ph.D., Hans G. Drexler, M.D., Ph.D., Akira Harashima, Ayumi Okochi, Masanori Daibata, M.D., Tetsuya Takakuwa, M.D., Kunzo Orita, M.D.

Blood (2004) 104 (11): 2295.

https://doi.org/10.1182/blood.V104.11.2295.2295

Published: 2004

NARROW

Evaluation of Azacitidine Clinical Efficacy in Patients with Myelodysplasia Syndrome Dudina G.a., Golenkov a.K., Kataeva E.V., Mitina T.a. Moscow Regional Clinical Research Institute

Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era

Increased Peripheral T Cell Responses to EBV-Infected Cells with Frequent Detection of EBV-DNA In Plasma and Viral mRNA In Peripheral B-Cells In Immunocompetent EBV-Positive Diffuse Large B-Cell Lymphoma Patients

Efficacy and Safety of a Single-Course of Yttrium-90 Ibritumomab Tiuxetan for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma after/not Appropriate for Autologous Stem Cell Transplantation - Final Analysis of a Phase II Trial of the European MCL Network.

Clinicopathological Features of Pyothorax-Associated Lymphoma; a Retrospective Survey Involving 98 Patients.

Efficacy and Safety of a Single-Course of Yttrium-90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed or Refractory Mantle Cell Lymphoma (MCL) After/Not Appropriate for Autologous Stem Cell Transplantation (ASCT) - A Phase II Trial of the European MCL Network.

Expression of Activation-Induced Cytidine Deaminase and Transcripts of Immunoglobulin Variable Heavy Chains in Mature B-Cell Lines Lacking Immunoglobulin Protein Expression.

Email alerts

ASH Publications

American Society of Hematology

Evaluation of Azacitidine Clinical Efficacy in Patients with Myelodysplasia Syndrome Dudina G.a., Golenkov a.K., Kataeva E.V., Mitina T.a. Moscow Regional Clinical Research Institute

Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era

Increased Peripheral T Cell Responses to EBV-Infected Cells with Frequent Detection of EBV-DNA In Plasma and Viral mRNA In Peripheral B-Cells In Immunocompetent EBV-Positive Diffuse Large B-Cell Lymphoma Patients

Efficacy and Safety of a Single-Course of Yttrium-90 Ibritumomab Tiuxetan for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma after/not Appropriate for Autologous Stem Cell Transplantation - Final Analysis of a Phase II Trial of the European MCL Network.

Clinicopathological Features of Pyothorax-Associated Lymphoma; a Retrospective Survey Involving 98 Patients.

Efficacy and Safety of a Single-Course of Yttrium-90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed or Refractory Mantle Cell Lymphoma (MCL) After/Not Appropriate for Autologous Stem Cell Transplantation (ASCT) - A Phase II Trial of the European MCL Network.

Expression of Activation-Induced Cytidine Deaminase and Transcripts of Immunoglobulin Variable Heavy Chains in Mature B-Cell Lines Lacking Immunoglobulin Protein Expression.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only